

Assistance is available to BC Cancer researchers at all sites across the province for any of the following:
For more information contact:
Karen Hagan khagan@bccancer.bc.ca
Jillian McKenna jmckenna@bccancer.bc.ca
BC Cancer Research IT provides timely and accurate delivery of support for researchers at the BCCRC, and has introduced a number of new applications available to all users.
Our support includes:
For assistance contact the BCCRC help desk: help@bccrc.ca
BC Cancer Research Building Operations provides building operational support including the implementation and maintenance of various operational programs, policies and procedures. The Building operations Leader is responsible for day-to-day building and facilities operations of the BCCRC.
Building operations services include:
The safety office is comprised of a Biosafety Officer and a Radiation Safety Officer and together they are responsible for the education and implementation of biosafety and radiation safety programs in all BC Cancer research labs as regulated by Health Canada, Worksafe BC, and the Canadian Nuclear Safety Commission.
Biosafety Officer- Elizabeth Hajen
Radiation Safety Officer- Dr. Greg Paliouras
The BCCRC’s Biosafety Program provides support to researchers in the following areas:
There are a number of resources available on the Safety Intranet and PHSA’s LearningHub in support of the Biosafety Program.
Email safetyoffice@bccrc.ca for assistance or call 604-675-8037.
BC Cancer Research Finance provides operational and administrative support, including the implementation, application and oversight of various financial policies, procedures and programs.
Information and assistance is available to BC Cancer researchers at all sites across the province for the following:
For help with these and other financial related matters, contact Debbie Mok: debbie.mok@bccancer.bc.ca
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.